Dapagliflozin Impurity 14, with the CAS number 2271248-78-1, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent dapagliflozin, which is used primarily in the treatment of type 2 diabetes. As an impurity, it may arise during the synthesis or degradation of dapagliflozin and is typically characterized by its molecular structure, which may differ slightly from the parent compound. The presence of impurities in pharmaceutical substances is critical to monitor, as they can affect the efficacy, safety, and regulatory compliance of the final product. While specific physical and chemical properties such as melting point, solubility, and spectral data may not be widely published, impurities like this are generally analyzed using techniques such as chromatography and mass spectrometry to ensure quality control in pharmaceutical manufacturing. Understanding the characteristics of such impurities is essential for maintaining the integrity of drug formulations and ensuring patient safety.

Dapagliflozin Impurity 14

2271248-78-1: Dapagliflozin Impurity 14, with the CAS number 2271248-78-1, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent dapagliflozin, which is used primarily in the treatment of type 2 diabetes. As an impurity, it may arise during the synthesis or degradation of dapagliflozin and is typically characterized by its molecular structure, which may differ slightly from the parent compound. The presence of impurities in pharmaceutical substances is critical to monitor, as they can affect the efficacy, safety, and regulatory compliance of the final product. While specific physical and chemical properties such as melting point, solubility, and spectral data may not be widely published, impurities like this are generally analyzed using techniques such as chromatography and mass spectrometry to ensure quality control in pharmaceutical manufacturing. Understanding the characteristics of such impurities is essential for maintaining the integrity of drug formulations and ensuring patient safety.

Dapagliflozin Impurity 4 (Mixture of Diastereomers)

(3R,4R,5R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol

CAS 2271248-78-1

Dapagliflozin Impurity 14

Dapagliflozin Impurity 4 (Mixture of Diastereomers)

Ref: 4Z-D-628

(3R,4R,5R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-5-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol

Ref: 54-OR1053184